. Carolyn Porter has 16 years’ experience spanning management, commercial and business development roles in the Biotech, Pharma, Finance and University sectors.  In her most recent role at Oxford University Innovation as Deputy Head of Technology Transfer she led or mentored the formation of 16 spin-out companies collectively raising £52M in seed financing and concluded some of the company’s largest licensing deals.  Carolyn has held board positions representing the University in 5 spin-out companies including OxStem.  Prior to this Carolyn held senior business development roles in Novartis Vaccines (Head of Search & Evaluation in Europe) and Chiron Vaccines (Business Development Director) working on in/out licensing, acquisitions and strategic alliances with deal values in excess of $1bn.  Her earlier career included working as a biotech analyst and then in Corporate Finance at Ernst & Young where she assisted companies with fundraising, acquisitions and company sales. Carolyn previously held post-doctoral positions at Oxford University in Biochemistry and Immunology. She has a PhD in Immunology from Trinity College Dublin, a first-class honors degree in Pharmacology from University College Dublin and an MBA from Warwick Business School.  She is a member of the Licensing Executives Society and the Pharmaceutical Licensing Group. . Carolyn Porter has 16 years’ experience spanning management, commercial and business development roles in the Biotech, Pharma, Finance and University sectors.  In her most recent role at Oxford University Innovation as Deputy Head of Technology Transfer she led or mentored the formation of 16 spin-out companies collectively raising £52M in seed financing and concluded some of the company’s largest licensing deals.  Carolyn has held board positions representing the University in 5 spin-out companies including OxStem.  Prior to this Carolyn held senior business development roles in Novartis Vaccines (Head of Search & Evaluation in Europe) and Chiron Vaccines (Business Development Director) working on in/out licensing, acquisitions and strategic alliances with deal values in excess of $1bn.  Her earlier career included working as a biotech analyst and then in Corporate Finance at Ernst & Young where she assisted companies with fundraising, acquisitions and company sales. Carolyn previously held post-doctoral positions at Oxford University in Biochemistry and Immunology. She has a PhD in Immunology from Trinity College Dublin, a first-class honors degree in Pharmacology from University College Dublin and an MBA from Warwick Business School.  She is a member of the Licensing Executives Society and the Pharmaceutical Licensing Group.

fermentation